The 10 largest medical device companies in the world


GE HealthcareNo. 4: GE Healthcare (General Electric)


2016 RANK: 4

Employees: 54,000

Revenue: $18,290,000,000

Fiscal year ending: Dec. 31, 2016


Key Personnel:

Kieran Murphy, president & CEO; Emmanuel Ligner, president & CEO, life sciences; Maher Abouzeid, president & CEO, Eastern growth markets; Terri Bresenham, president & CEO, sustainable healthcare solutions; Sean Burke, president & CEO, Asia Pacific; Lee Cooper, president & CEO, U.S. & Canada; Jörg Debatin, VP & CTO; Rachel Duan, president & CEO, China; Laurent Dubois, CEO, GE Healthcare Partners; James Richards, CIO; Karim Karti, president & CEO, imaging; Charles Koontz, president & CEO, GE Healthcare IT & chief digital officer; Raghu Krishnamoorthy, VP, HR; Jean-Michel Malbrancq, president & CEO, Europe; Thomas Mitchell, VP, sourcing; Chuck Nugent, VP, global supply chain; Laura O’Donnell, VP & General Counsel; Monish Patolawala, VP & CFO; Sue Siegel, CEO, GE Ventures & healthymagination; Daurio Speranzini Jr., president & CEO, Latin America; Thomas Westrick, VP & chief quality officer; Sarah Wills, chief communications officer; Anders Wold, president & CEO, clinical care solutions


John Flannery, who is slated to assume the corner office at General Electric in 2018, has served as chief executive of the company’s healthcare division since 2014. There, he helped to turn around GE Healthcare, growing organic revenue by 5% and margins by 100 base points last year.

Under Flannery’s watch, the healthcare unit inked a number of deals, including a development and manufacturing deal with Check-Cap – a company developing an indigestible capsule designed for colorectal screening.

GE Healthcare also partnered with Accuray last year, collaborating on financing options for Accuray’s CyberKnife and TomoTherapy Systems. The deal, which is designed to make it easier for clinicians in Europe to offer the systems, will allow hospitals and healthcare practitioners to lease Accuray equipment and services through a turnkey offering.

In regulatory news, the FDA approved label changes for GE Healthcare’s ultrasound contrast agent, Optison. The decision removed contraindications for use in patients with cardiac shunts and for administration by intra-arterial injection – it’s the first contrast agent available in the U.S. to receive this label change, according to GE.

The company landed a reimbursement win when Cigna revised its coverage to include 3D mammography for routine breast cancer screening. GE Healthcare is one of only two companies with mammography systems on the market in the U.S. that can perform 3D breast tomosynthesis.


Download the full Big 100 list here.

And you can also pick up a free hard copy of the Big 100 issue at DeviceTalks Boston on Oct. 2!


How do you know your technology is disruptive enough to break conventional wisdom?

textadimage Stan Rowe knows a little something about bringing disruptive technology to market. The current Edwards Lifesciences CSO was in on the ground floor of two of medtech's most disruptive treatments, stents and transcatheter aortic valve replacement.

On December 12th, Rowe will sit down with MassDevice editor Brad Perriello for a long ranging discussion about the inside story on how these technologies came to market and what Rowe learned along the way.

Register now with the code "TAVR" and save 15% today.

Pages: 1 2 3 4 5 6 7 8 9 10 11

Speak Your Mind